carbidopa has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Göktürk, C; Nordquist, JE; Oreland, L | 1 |
| Barthelmebs, M; Froehly, S; Grima, M; Imbs, JL; Stephan, D; Vailly, B; Velly, J | 1 |
2 other study(ies) available for carbidopa and Alloxan Diabetes
| Article | Year |
|---|---|
Semicarbazide-sensitive amine oxidase (SSAO) gene expression in alloxan-induced diabetes in mice.
Topics: Adipose Tissue; Alloxan; Amine Oxidase (Copper-Containing); Animals; Blood Glucose; Carbidopa; Diabetes Mellitus, Experimental; Gene Expression Regulation, Enzymologic; Hydralazine; Lung; Male; Mice; RNA, Messenger | 2002 |
Effects of dopamine prodrugs and fenoldopam on glomerular hyperfiltration in streptozotocin-induced diabetes in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Carbidopa; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dopamine Agents; Fenoldopam; Glomerular Filtration Rate; Hemodynamics; Levodopa; Male; Prodrugs; Rats; Rats, Inbred Strains; Streptozocin | 1991 |